todE Antibody

What is todE Antibody and what is its target protein?

todE Antibody (product code CSB-PA320228XA01FRZ) is a research-grade antibody targeting the todE protein (UniProt accession P13453) from Pseudomonas putida (strain ATCC 700007 / DSM 6899 / BCRC 17059 / F1). The todE protein is part of the toluene degradation pathway in this bacterial species, functioning within a metabolic cascade that enables the bacterium to utilize toluene as a carbon source . Similar to antibody production methods described in comparative studies, todE Antibody is likely produced through immunization of host animals with purified protein or synthetic peptides, followed by hybridoma technology to generate monoclonal antibodies or affinity purification for polyclonal versions .

What are the common applications of todE Antibody in bacterial research?

todE Antibody serves several critical functions in research applications:

• Protein Detection: Western blotting to confirm protein expression in wild-type vs. mutant bacterial strains

• Localization Studies: Immunofluorescence to determine subcellular localization of todE protein

• Protein-Protein Interaction Analysis: Immunoprecipitation to identify binding partners

• Expression Level Monitoring: ELISA-based quantification during toluene metabolism

• Functional Studies: Neutralization experiments to assess todE's role in aromatic compound degradation

Similar to approaches used with other bacterial proteins, researchers typically employ epitope mapping techniques to characterize binding specificity, using "libraries of overlapping synthetic peptides" to confirm target recognition .

How should todE Antibody be stored and handled for optimal performance?

Based on standard antibody handling protocols, researchers should observe these guidelines:

For western blotting applications, researchers typically prepare working dilutions in the 1:500-1:5000 range in appropriate blocking buffer, while immunoprecipitation applications may require 2-5 μg of antibody per sample .

What control samples should be included when using todE Antibody?

When designing experiments with todE Antibody, the following controls are essential:

• Positive Control: Lysate from Pseudomonas putida expressing todE protein

• Negative Control: Lysate from todE knockout strains of Pseudomonas putida

• Secondary Antibody Control: Samples processed without primary antibody to check for non-specific binding

• Loading Control: Detection of a housekeeping protein (e.g., RNA polymerase subunit) to normalize expression levels

• Specificity Control: Pre-incubation of antibody with purified todE protein to confirm binding specificity

These controls help ensure experimental validity and support proper interpretation of results, particularly when assessing specificity of signal in complex bacterial samples .

How can epitope mapping be performed to characterize todE Antibody binding sites?

Epitope mapping for todE Antibody can be conducted using several complementary approaches:

• Peptide Array Analysis: Following established protocols, researchers can use "libraries of overlapping synthetic peptides" covering the full sequence of todE protein with 16-18 amino acid peptides that overlap by 16 amino acids with adjacent peptides. Binding capacity can be determined via ELISA-based methods .

• Mutagenesis Studies: Systematic site-directed mutagenesis of key residues within the predicted epitope region, followed by western blotting to identify critical binding determinants.

• Competition Assays: Pre-incubation of antibody with wild-type or mutated peptides (50 μg/ml) for 2 hours at room temperature before addition to coated ELISA plates can reveal specific binding requirements .

• Hydrogen-Deuterium Exchange Mass Spectrometry: This technique can identify regions of the protein that are protected from exchange when bound by the antibody, indicating potential epitopes.

The resultant epitope map provides crucial information for interpreting experimental results and potential cross-reactivity with related bacterial proteins.

What methodologies can resolve cross-reactivity issues with todE Antibody?

When facing cross-reactivity challenges with todE Antibody, researchers can employ several strategic approaches:

• Affinity Purification: Passing the antibody through a column with immobilized cross-reactive proteins to deplete antibodies recognizing shared epitopes.

• Pre-adsorption: Pre-incubating the antibody with lysates from bacteria lacking todE but containing potential cross-reactive proteins before using in the final application.

• Peptide Blocking: Similar to competition assays used in epitope mapping, specific peptides corresponding to unique regions of todE can block specific antibody binding while leaving cross-reactive binding intact, helping to identify the source of cross-reactivity .

• Western Blot Analysis: Comparing binding patterns across various Pseudomonas species with known sequence variations in todE homologs.

• Targeted Recombinant Fragments: Testing antibody reactivity against recombinant fragments of todE to identify which regions contribute to specificity versus cross-reactivity.

Documentation of these validation steps strengthens the reliability of research findings and helps troubleshoot unexpected results.

How can researchers optimize immunoprecipitation protocols for todE Antibody?

Optimizing immunoprecipitation (IP) with todE Antibody requires attention to several critical factors:

• Lysis Buffer Composition: For bacterial proteins like todE, lysis buffers should contain:

  • Protease inhibitors (Complete Mini, EDTA-free Protease Inhibitor Cocktail)

  • 250 mM Pefabloc SC

  • 1 mg/ml TLCK

  • 5 mM EDTA

• Cross-linking Considerations: For transient interactions, consider using DSP (dithiobis(succinimidyl propionate)) or formaldehyde cross-linking prior to cell lysis.

• Antibody Coupling Method:

  Coupling Method	Advantage	Limitation
  Protein A/G Beads	Simple protocol	Heavy chain interference in WB
  Direct Covalent Coupling	No antibody contamination	Reduced antibody flexibility
  Magnetic Beads	Faster processing	Higher cost

• Wash Stringency Optimization: Testing increasing salt concentrations (150-500 mM NaCl) to reduce non-specific binding while maintaining specific interactions.

• Elution Strategies: For downstream applications sensitive to harsh elution conditions, consider native elution with excess peptide antigen rather than denaturing SDS elution .

Successful IPs can confirm protein-protein interactions critical to understanding todE's role in toluene degradation pathways.

What factors influence the detection sensitivity of todE in complex bacterial samples?

Several factors can significantly impact detection sensitivity when working with todE Antibody:

• Sample Preparation Variables:

  • Bacterial growth phase (exponential vs. stationary)

  • Induction conditions (presence/absence of toluene)

  • Lysis method (mechanical disruption vs. enzymatic)

  • Subcellular fractionation efficiency

• Detection System Optimization:

  • Signal amplification methods (standard ECL vs. Femto ECL)

  • Membrane selection (PVDF vs. nitrocellulose)

  • Blocking agent composition (milk vs. BSA)

  • Primary antibody incubation time and temperature

• Quantitative Considerations:

  • Linear dynamic range determination

  • Standard curve preparation with purified recombinant todE

  • Use of internal reference proteins for normalization

• Technical Enhancements:

  • Signal-to-noise ratio improvement through optimized washing

  • Background reduction strategies

  • Detection limit determination

Understanding these variables allows researchers to develop robust protocols tailored to their specific experimental needs and sample characteristics.

How should researchers design experiments to study todE protein modification states?

Investigating todE protein modifications requires systematic experimental design:

• Identification of Potential Modifications:

  • Computational prediction of phosphorylation, acetylation, or other modification sites

  • Comparison with known modifications in homologous proteins

• Targeted Antibody Selection Strategy:

  • Consider developing modification-specific antibodies similar to phosphorylation-dependent antibodies described in other studies

  • Use paired antibodies (modification-specific and total protein) for comparative analysis

• Validation Methodology:

  • Treatment with specific phosphatases or deacetylases to confirm modification-dependent signal

  • Site-directed mutagenesis of putative modification sites

  • Mass spectrometry confirmation of modifications

• Functional Correlation Approaches:

  • Correlation of modification states with environmental conditions

  • Assessment of enzyme activity relative to modification status

  • Protein-protein interaction changes dependent on modification state

This comprehensive approach enables researchers to connect protein modifications with functional outcomes in toluene degradation pathways.

What are the best approaches for quantifying todE expression levels across experimental conditions?

Accurate quantification of todE expression requires selection of appropriate methodologies based on experimental objectives:

• Western Blot Quantification:

  • Establish linear dynamic range using purified recombinant todE protein

  • Use digital image analysis with appropriate normalization to housekeeping proteins

  • Employ technical replicates (minimum n=3) for statistical validation

• ELISA Development Considerations:

  • Direct coating vs. sandwich ELISA comparison

  • Standard curve preparation with purified todE protein

  • Validation of assay specificity using knockout bacterial strains

• qPCR Correlation Studies:

  • Design of todE-specific primers

  • Validation of reference genes stable under experimental conditions

  • Correlation analysis of mRNA vs. protein levels across conditions

• High-throughput Screening Applications:

  • Miniaturized assay formats for multiple condition testing

  • Automated image analysis for immunofluorescence-based quantification

  • Statistical approaches for handling large datasets

Each method offers distinct advantages depending on sample type, required sensitivity, and throughput needs.

How can researchers validate antibody specificity when working with environmental Pseudomonas isolates?

When extending research to environmental isolates, validating todE Antibody specificity becomes particularly important:

• Sequence Analysis Approach:

  • Bioinformatic comparison of todE sequences across Pseudomonas species

  • Identification of conserved vs. variable regions corresponding to antibody epitopes

  • Prediction of potential cross-reactivity based on sequence homology

• Multi-method Validation Strategy:

  • Western blot analysis of recombinant todE variants

  • Immunoprecipitation followed by mass spectrometry identification

  • Immunofluorescence with co-localization studies

• Genetic Confirmation Techniques:

  • CRISPR-Cas9 knockout of todE in environmental isolates

  • Complementation studies with tagged todE variants

  • Correlation of antibody signal with genetic presence/absence

• Cross-Absorption Studies:

  • Pre-incubation with lysates from related non-target species

  • Sequential immunoprecipitation to identify shared epitopes

  • Competition assays with defined peptide fragments

These approaches ensure reliable application of todE Antibody across diverse environmental isolates with potential sequence variations.

How should researchers interpret contradictory results when using todE Antibody across different detection methods?

When faced with discrepancies between detection methods, consider these systematic evaluation approaches:

• Method-Specific Interference Analysis:

  • Western blotting: Evaluate protein extraction efficiency, transfer conditions, and blocking reagents

  • ELISA: Assess matrix effects, hook effects at high concentrations, and detection antibody specificity

  • Immunofluorescence: Consider fixation artifacts, accessibility of epitopes, and subcellular compartmentalization

• Epitope Accessibility Evaluation:

  • Different methods may expose or mask epitopes differently

  • Denaturation in western blotting versus native conditions in ELISA

  • Consider using multiple antibodies targeting different epitopes

• Sample Preparation Variables:

  • Lysis conditions may differently affect protein complexes or modifications

  • Fixation methods in immunofluorescence may alter epitope recognition

  • Storage conditions between sample preparation and analysis

• Antibody Performance Characteristics:

  • Concentration-dependent specificity changes

  • Buffer compatibility issues

  • Lot-to-lot variability assessment

What strategies can resolve non-specific binding issues with todE Antibody in immunoblotting?

Non-specific binding in immunoblotting can be addressed through systematic optimization:

• Blocking Optimization Matrix:

  Blocking Agent	Starting Concentration	Optimization Range
  Non-fat milk	5%	1-10%
  BSA	3%	1-5%
  Casein	1%	0.5-2%
  Commercial blockers	Per manufacturer	Variable

• Washing Protocol Refinement:

  • Increased wash duration (5-15 minutes per wash)

  • Additional wash steps (3-5 washes)

  • Detergent concentration adjustment (0.05-0.3% Tween-20)

  • Inclusion of low salt (50-150 mM NaCl) in wash buffers

• Antibody Dilution Optimization:

  • Serial dilution testing to identify optimal signal-to-noise ratio

  • Use of antibody diluents containing stabilizers and carriers

  • Overnight incubation at 4°C versus shorter incubations at room temperature

• Pre-adsorption Strategies:

  • Pre-incubation with non-target bacterial lysates

  • Use of membrane strips containing non-specific proteins

  • Commercial antibody pre-adsorption reagents

Methodical testing of these variables enables development of robust protocols with minimal background interference.

How can researchers differentiate between isoforms or processed forms of todE protein?

Differentiating todE variants requires integration of complementary techniques:

• Gel Resolution Optimization:

  • Gradient gels (8-16%) for wide molecular weight range separation

  • Extended electrophoresis times for closely migrating species

  • Phos-tag gels for phosphorylation-dependent mobility shifts

• Epitope-Specific Antibody Applications:

  • Domain-specific antibodies targeting different regions of todE

  • Post-translational modification-specific antibodies if relevant

  • Strategic use of N-terminal versus C-terminal targeting antibodies

• Complementary Protein Characterization:

  • Mass spectrometry for definitive identification of variants

  • 2D gel electrophoresis for charge-based separation

  • Limited proteolysis followed by western blotting to identify domain structures

• Genetic Validation Approaches:

  • Expression of tagged truncation variants as migration standards

  • Site-directed mutagenesis of processing sites

  • Time-course studies of expression and processing

This multi-faceted approach enables confident assignment of signals to specific todE protein variants in complex samples.

How can todE Antibody be utilized in studies of bacterial community dynamics during bioremediation?

todE Antibody offers unique capabilities for monitoring toluene degradation pathways in complex environmental contexts:

• Community-Level Analysis Applications:

  • Immunofluorescence microscopy to identify todE-expressing bacteria within mixed communities

  • Flow cytometry with fluorescently-labeled todE Antibody for quantitative population assessment

  • Immunomagnetic separation to isolate todE-expressing bacteria from environmental samples

• Functional Correlation Approaches:

  • Combined immunodetection with activity assays to link protein presence with degradation rates

  • In situ hybridization paired with immunodetection to connect genotype and phenotype

  • Time-course studies correlating todE expression with toluene disappearance

• Method Development Considerations:

  • Sample preparation optimization for soil, water, and biofilm matrices

  • Signal amplification strategies for low-abundance detection

  • Multiplexing with antibodies against other degradation pathway components

• Validation Requirements:

  • Controls for non-specific binding to environmental matrices

  • Spike-recovery experiments with known quantities of target bacteria

  • Comparison with molecular methods targeting todE genes

These applications extend the utility of todE Antibody beyond conventional laboratory research into field-relevant bioremediation contexts.

What considerations are important when developing proximity ligation assays using todE Antibody?

Proximity Ligation Assays (PLA) offer powerful insights into protein-protein interactions involving todE:

• Antibody Pair Selection Criteria:

  • Compatibility of host species for secondary antibody recognition

  • Epitope mapping to ensure non-competitive binding to todE

  • Validation of each antibody individually before combination

• Assay Optimization Parameters:

  • Fixation conditions preserving native protein complexes

  • Permeabilization methods maintaining structural integrity

  • Blocking reagents minimizing non-specific oligonucleotide binding

  • Incubation times for optimal signal development

• Control Design Requirements:

  • Biological controls: known interaction partners versus non-interacting proteins

  • Technical controls: primary antibody omission, single antibody controls

  • Specificity controls: competition with excess antigen

• Quantification Approaches:

  • Signal intensity versus dot counting methodologies

  • Statistical analysis of spatial distribution patterns

  • Correlation with other interaction detection methods

PLA provides valuable spatial context for understanding todE interactions within bacterial cells that complement traditional biochemical approaches.

How can todE Antibody be integrated with mass spectrometry for comprehensive protein characterization?

Combining immunological and mass spectrometry approaches creates powerful workflows for todE characterization:

• Immunoprecipitation-Mass Spectrometry (IP-MS):

  • Enrichment of todE and interacting proteins using optimized IP protocols

  • Sample preparation considering compatibility with downstream MS analysis

  • Data analysis identifying post-translational modifications and interaction partners

• Selected Reaction Monitoring (SRM) Assay Development:

  • Antibody-based enrichment followed by targeted MS quantification

  • Selection of peptide targets unique to todE for absolute quantification

  • Method validation across diverse sample types

• Cross-linking MS Applications:

  • In vivo cross-linking to capture transient interactions

  • Immunopurification of cross-linked complexes

  • MS identification of interaction interfaces

• Comparative Proteomic Analysis:

  • Correlation of western blot quantification with MS-based proteomics

  • Validation of MS findings with orthogonal antibody-based detection

  • Integration of data from multiple analytical platforms

This integrated approach provides complementary strengths, combining the specificity of antibody-based methods with the comprehensive analysis capabilities of mass spectrometry.

What experimental design principles should guide temporal studies of todE expression during toluene metabolism?

Temporal studies require careful experimental design to capture dynamic expression patterns:

• Sampling Strategy Optimization:

  • Time point selection based on known toluene degradation kinetics

  • Consideration of bacterial growth phase effects

  • Sample preservation methods maintaining protein integrity

• Quantification Method Selection:

  • Western blotting with digital image analysis for moderate throughput

  • ELISA development for high-throughput quantification

  • Single-cell approaches (flow cytometry, immunofluorescence) for population heterogeneity assessment

• Data Normalization Approaches:

  • Selection of stable reference proteins across time points

  • Total protein normalization methods (Stain-Free technology, Ponceau S)

  • Consideration of changing cell densities during growth

• Statistical Analysis Requirements:

  • Appropriate replication (biological and technical)

  • Time-series statistical methods

  • Correlation analysis with substrate disappearance rates

Carefully designed temporal studies can reveal regulatory mechanisms governing todE expression in response to environmental conditions.